- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01705821
Forces During Skull Base Surgery
Measuring Forces Applied During Skull Base Surgery
Study Overview
Status
Conditions
Detailed Description
At some time in their lives, 1 in 5 people will have a pituitary tumor, and 1 in 600 of these will have the tumor grow large enough (>1 cm in diameter) that surgical resection is required. Traditionally, surgery to remove pituitary tumors or other tumors at the skull base requires transcranial or transfacial access. In these approaches, large traumatic, often disfiguring, openings must be created in the patient's forehead or cheek. Endonasal skull base surgery reduces invasiveness resulting in less trauma, fewer complications, and shorter surgical time. However, despite the compelling advantages for the patient, only a small percentage of skull base surgeries are done endonasally. While exact statistics are not available, the current best estimate in the literature is that less than 50% and most likely less than 20% of these tumors are addressed by endonasal surgery.
The endonasal approach is underemployed despite its demonstrated benefits to the patient because existing surgical instruments have limited dexterity and approach angles, and simultaneously manipulating several of them through a nostril while performing complex surgical procedures is so technically challenging that only a small number of expert surgeons can accomplish it. Even for these experts, mortality rates are non-negligible (0.9%), and there remain contraindications to the endonasal approach, including occlusion of the surgical site by delicate and critical neurovascular structures (e.g. carotid arteries, optic nerves), inability to fully reconstruct the dura due to lack of surgical tool dexterity, and long surgical duration. All of these contraindications are directly related to limitations in instrument dexterity and visualization, which motivates the development of a robotic system for endonasal skull base surgery. Such a robot can potentially increase surgical dexterity and reduce the technical complexity of the procedure for surgeons, thereby increasing the percentage of patient who benefit from the endonasal technique.
While many robotic systems have been developed for intravascular interventions as well as natural orifice surgery though other orifices, comparatively few systems have been targeted at endonasal surgery. This is likely due to the smaller size of the nasal cavity and nostril compared to other natural orifices.
For endonasal robots, the limited space available in the nostril opening, combined with the need to work dexterously within the cavities in the head, implies that instrument shafts must be small in diameter while enabling dexterous motions of instrument tips. A recently invented robot design that matches these characteristics is the concentric tube robot concept, which is also known as by the name active cannula.
A robot suitable for endonasal surgery is being developed (see reference #3), however in order to optimize this robotic system, intraoperative data must be obtained to determine how the robot interacts with the patient's tissues. The aim of this study is to modify a traditional tool used in the operating room to allow determination of forces at the skull base on both hard and soft tissues. This surgical curette will be used in the standard fashion during endonasal skull base surgery, however will provide valuable information.
The modified curette will consist of two segments joined by a Nano17 6-axis force sensor. (Image 1) The force sensor is integrated into the shaft of the instrument (a standard neurosurgical ring curette) and insulated from the shaft with two polyetherimide (also known as ULTEM) disks so that no current can be transmitted from the force sensor to the curette. The sensor is held to the shaft by medical grade adhesive and set screws.
The patients will be recruited from the PIs clinical practice. Informed consent will be obtained. At the appropriate time during surgery this curette will be used to collect force date. This force transducer operates at 5V (4.8-9V range). These transducers are commonly used in medical and dental research (see reference #5).
No additional operating room or anesthesia time will be required.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37212
- Vanderbilt University Skull Base Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion criteria:
- Any male or female patient 18-75 years old undergoing endonasal skull base surgery for a skull base lesion.
- Competent in decision making process and able to sign a written informed consent form.
Exclusion Criteria:
-Any patient not able to give written informed consent.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Skull Base Surgery Candidate
Patient with a skull base lesion will undergo use of standard surgical curette with force sensor built into shaft.
6-axis force and torque data will be collected during the surgical procedure.
|
Use of a standard surgical curette outfitted with an in-line 6-axis force and torque transducer for collection of force data during surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6-axis force and torque data from routine endoscopic transnasal skull base surgery
Time Frame: 12 months
|
This data will be collected and recorded via a computer interface with our sensorized tool and recorded in standard units for force and torque.
We will also look at the variability of forces between patients after collecting this data.
The data will be useful in optimizing a robotic system for endonasal surgery as described in the secondary outcome measure.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent tumor removal in skull and cadaver studies
Time Frame: 12 months
|
The force and torque data will allow our team of Engineers to optimize our robotic system to be best suited for removing pituitary tumors transnasally.
The robot consists of specially designed flexible arms with end effectors that each need to be able to withstand and produce the necessary forces to complete pituitary tumor excision.
This will be measured by optimizing our robot based on the findings in the primary outcome measure and then evaluating the robot for efficiency and effectiveness of mock pituitary tumor removal from skull and cadaver specimens.
We will investigate percent tumor removal and speed of tumor removal once the robot is optimized.
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Robert Webster, PhD, Vanderbilt University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 121194
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pituitary
-
Memorial Sloan Kettering Cancer CenterCompletedPituitary | Pituitary Tumor | Pituitary Cancer | Pituitary CarcinomaUnited States
-
Hospices Civils de LyonRecruitingCushing Disease | ACTH-producing Pituitary TumourFrance
-
Barts & The London NHS TrustRecruitingAcromegaly | Gigantism | Familial Isolated Pituitary Adenoma | FIPA | Pituitary Adenoma Predisposition | PAPUnited Kingdom
-
University Medical Center GroningenCompletedPituitary Adenoma | Pituitary Tumor | Pituitary MacroadenomaNetherlands
-
Zhaoyun ZhangUnknownPituitary TumorChina
-
Nova Scotia Health AuthorityNova Scotia Health AuthorityWithdrawnPituitary Dysfunction
-
Tiburio TherapeuticsNot yet recruitingNon-Functional Pituitary Adenoma | Pituitary Tumor, Nonfunctioning
-
Dartmouth-Hitchcock Medical CenterTerminatedPituitary MacroadenomaUnited States
-
University of Texas Southwestern Medical CenterTerminatedPituitary MacroadenomaUnited States
-
Assiut UniversityUnknown
Clinical Trials on Use of force sensing surgical curette
-
Adhera Health, Inc.Hospital Universitario Miguel Servet, ZaragozaCompleted
-
Groupe Hospitalier Paris Saint JosephCompleted
-
Intuitive SurgicalNot yet recruiting
-
Medizinische Hochschule Brandenburg Theodor FontaneIntuitive FoundationActive, not recruitingRobotic Surgical Procedures | Outcome Assessment | Colorectal Cancer (CRC) | Laparoscopic Abdominal Surgery
-
Groupe Hospitalier Paris Saint JosephCompletedAcetabular Fracture | Acetabular SurgeryFrance
-
The Methodist Hospital Research InstituteTerminatedHeart Failure | Ventricular DysfunctionUnited States
-
Christie Medical Holdings, Inc.TerminatedPerfusion; ComplicationsUnited States
-
Virtual Incision CorporationEnrolling by invitation
-
University of L'AquilaCompleted
-
Regina Elena Cancer InstituteIstituto Ortopedico Galeazzi; Azienda Policlinico Umberto IRecruitingNeoplasms | Muscle NeoplasmItaly